HomeInsights52 Week Low Stocks

Procter & Gamble Health Ltd 52 Week Low

Procter & Gamble Health Ltd 52 Week Low

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

0.1 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Procter & Gamble Health Ltd

NSE: PGHL

YEARLOW

₹ 4640.3

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week Low of Procter & Gamble Health Ltd is ₹ 4640 as of 26 Dec 24 .

Company Fundamentals for Procter & Gamble Health Ltd

No data available

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20245446.35
24 Dec 20245397.4
23 Dec 20245431.3
20 Dec 20245450.35
19 Dec 20245504.9
18 Dec 20245472.9
17 Dec 20245520.05
16 Dec 20245624.4
13 Dec 20245676.8
12 Dec 20245679.65

Asset Value vs Market Value of Procter & Gamble Health Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Procter & Gamble Health Ltd News Hub

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 2024 09:59

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

28 Sep 2024 10:06

News

Procter & Gamble Health schedules AGM

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the compan...

Read more

23 Aug 2024 11:48

News

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, ...

Read more

22 Aug 2024 10:02

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

21 Aug 2024 17:54

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 21...

Read more

28 Jun 2024 11:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Procter & Gamble Health Ltd

Why is it important to track the 52-week low of Procter & Gamble Health Ltd stocks?

Investors should monitor the 52-week low of Procter & Gamble Health Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Procter & Gamble Health Ltd stocks hitting a 52-week low?

Factors leading to Procter & Gamble Health Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Procter & Gamble Health Ltd stocks when they hit a 52-week low?

Buying Procter & Gamble Health Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Procter & Gamble Health Ltd stocks?

Investors should monitor the 52-week low of Procter & Gamble Health Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Procter & Gamble Health Ltd stock at their 52-week low?

An investor can analyze the reasons for the Procter & Gamble Health Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Procter & Gamble Health Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Procter & Gamble Health Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Procter & Gamble Health Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions